Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Kimia Farma Persero TbkISX:KAEF +0.91%57 Median PS Value is Rp1,382.04 as of Aug. 20, 2026, which is 100% below its 10-year median of 0.35. GuruFocus rates ISX:KAEF with a GF Score™ of 57/100 and a GF Value™ of Rp579.78 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 69 Medical Distribution companies, PT Kimia Farma Persero Tbk ranks better than 91.3% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for PT Kimia Farma Persero Tbk's Median PS Value or its related term are showing as below:
ISX:KAEF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.2 Med: 0.35 Max: 1.58
Current: 0.32
During the past 13 years, the highest Price to Median PS Value of PT Kimia Farma Persero Tbk was 1.58. The lowest was 0.20. And the median was 0.35.
ISX:KAEF's Price-to-Median-PS-Value is ranked better than 91.3% of 69
companies
in the Medical Distribution industry
Industry Median: 0.74
vs ISX:KAEF: 0.32
PT Kimia Farma Persero Tbk (ISX:KAEF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
PT Kimia Farma Persero Tbk's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
442.00
/
1,382.04
=
0.32
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Persero Tbk Median PS Value Related Terms
PT Kimia Farma Persero Tbk Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:KAEF vs MCK, COR, CAH: Median PS Value Comparison
For the Medical Distribution subindustry, PT Kimia Farma Persero Tbk's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Persero Tbk Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Persero Tbk's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Persero Tbk's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.8051.
PT Kimia Farma Persero Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp1716.612.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Persero Tbk (ISX:KAEF) has a Median PS Value of Rp1,382.04 as of Aug. 20, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PT Kimia Farma Persero Tbk and its competitors. This is 394769% above median its historical median of 0.35. Over the past decade, PT Kimia Farma Persero Tbk's Median PS Value has ranged from 0.20 to 1.58. According to the industry distribution chart, PT Kimia Farma Persero Tbk ranks #6 out of 69 companies in the Medical Distribution industry, placing it in the top 8.7%.
Is PT Kimia Farma Persero Tbk's Median PS Value too high?
PT Kimia Farma Persero Tbk's current Median PS Value of Rp1,382.04 is 394769% above median its 10-year median of 0.35. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 1.58. Based on the distribution chart, PT Kimia Farma Persero Tbk ranks #6 out of 69 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's Median PS Value compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Kimia Farma Persero Tbk ranks #6 out of 69 companies for Median PS Value. This places PT Kimia Farma Persero Tbk in the top 9% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.74. Historically, PT Kimia Farma Persero Tbk's own Median PS Value has ranged from 0.20 to 1.58 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.74, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PT Kimia Farma Persero Tbk and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kimia Farma Persero Tbk's current Median PS Value is Rp1,382.04, which is 394769% above median its own 10-year median of 0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp579.78, compared to a current price of Rp442.00 — trading 23.8% below its estimated fair value. The current Median PS Value is Rp1,382.04, which is 394769% above median its 10-year median of 0.35. PT Kimia Farma Persero Tbk's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current Median PS Value is Rp1,382.04 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued.
The current stock price of Rp442.00 is trading 23.8% below its estimated GF Value™ of Rp579.78.
GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.
Key valuation signals for ISX:KAEF:
Median PS Value: Rp1,382.04 (394769% above median its 10-year median of 0.35)
GF Value™: Rp579.78 vs. price of Rp442.00 (23.8% below fair value)
No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
57GF Score
Get the complete analysis for ISX:KAEF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KAEF has been successfully added to your 
